Terry Dagnon - 03 Dec 2021 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role
Chief Operating Officer
Signature
/s/ Lawrence Kenyon, Attorney-in-Fact
Issuer symbol
OTLK
Transactions as of
03 Dec 2021
Net transactions value
+$14,200
Form type
4
Filing time
03 Dec 2021, 15:32:42 UTC
Next filing
06 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLK Common Stock Purchase $14,200 +10,000 +0.89% $1.42 1,137,857 03 Dec 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.